30 August 2018

Panama City, August 30th, 2018 – Hitachi, Ltd. (Hitachi), Ansaldo STS SpA (Ansaldo STS), a group company of Hitachi and Mitsubishi Corporation today announced that they have signed a memorandum of understanding with Metro de Panamá, S.A. (MPSA) to provide a monorail system for Line 3 of Panama Metro.


Image of a monorail system for Line 3 of Panama Metro

The prime contractor for the project, including the civil works portions, will be selected by MPSA, and the subcontractor contract will be signed by the prime contractor and the companies.

Hitachi will provide 28 six-car trains. Signaling systems, telecommunication systems and power systems will be delivered by Ansaldo STS. Mitsubishi Corporation will be in charge of commercial affairs.

The Japan International Cooperation Agency will provide yen-loan to support the improvement of urban transportation systems and efforts to combat climate change, which will be allocated to civil works projects and the procurement of the monorail system.

Outline of Project

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges, combining its operational technology, information technology, and products/systems. The company’s consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

Contacts

US

Tamie Nagamoto
Hitachi America, Ltd.
+1-914-333-2987
tamie.nagamoto@hal.hitachi.com

 

17 December 2018

This information was filed with and made public at the Tokyo Stock Exchange at 15:00 on December 17, 2018 JST.

News Release
Presentation Material

Press Contacts

Kazuko Amamoto
Hitachi, Ltd.
+81-3-5208-9323
kazuko.amamoto.oo@hitachi.com

Keisaku Shibatani
Hitachi, Ltd.
+81-3-4564-4517
keisaku.shibatani.tj@hitachi.com

17 January 2019

This information was filed with and made public at the Tokyo Stock Exchange at 18:00 on January 17, 2019 JST.

News Release

Press Contacts

Masatoshi Terashi
Hitachi, Ltd.
+81-3-5208-9323
masatoshi.terashi.hw@hitachi.com

 

27 February 2019

-- System leverages artificial intelligence and shared decision-making to improve patient care at a low financial cost --

Tokyo, February 27, 2019 --- University of Utah Health (U of U Health) and Hitachi, Ltd. (TSE: 6501, Hitachi) today announced that U of U Health has begun a prospective clinical study of a pharmacotherapy selection system(1) co-developed with Hitachi at 13 primary care clinic sites starting from February 2019. The system supports patients and providers in selecting Type 2 diabetes mellitus(2) (T2DM, the most common form of diabetes) treatment options by showing side-by-side comparisons of predicted treatment effect, risks and side effects, as well as costs for multiple medication regimens. By facilitating patient-provider communication and shared-decision making support, the aim is to keep patients fully engaged and committed to their treatment plan. U of U Health and Hitachi will evaluate the clinical and financial impact of the system.

Healthcare informatics research that leverages the vast amount of medical data accumulated at medical institutions for healthcare improvement and efficiency holds great promise. To leverage machine learning or artificial intelligence in healthcare, it is necessary to incorporate various data from the electronic health record (EHR) in real time. U of U Health and Hitachi developed the pharmacotherapy selection system, which consists of U of U Health’s standards-based clinical decision support system (OpenCDS(3)), which employs the HL7® FHIR®(4) RESTful(5) API (Application Programming Interface), and Hitachi’s machine learning-based pharmacotherapy outcome prediction technology. Since the announcement of the co-developed pharmacotherapy selection system in March 2018, U of U Health and Hitachi have continued to improve the system according to the concept of Hybrid Learning,(6) which combines machine learning with clinical knowledge with a goal of improving the system’s usefulness in the clinic. Improvements that have been made to the system include the addition of functions to predict the effect of weight loss on hemoglobin A1c levels (HbA1c), as well as the incorporation of clinical guideline recommendations based on a patient’s comorbidities.

As the next step towards leveraging the system for improved patient care, a prospective study has been started at 13 primary care clinic sites. Primary care clinics are randomized to either an intervention arm where the tool is available or to a control arm where the tool is not yet available. The system’s impact on outcomes such as patients’ HbA1c value(7) and the cost of prescribed pharmacotherapies will be evaluated.

Through this clinical evaluation, U of U Health and Hitachi will continue their joint research efforts with a goal of improving the health and well-being of patients living with diabetes.

(1)

12 March 2018 News Release: Pharmacotherapy selection system supports shared clinician-patient decision-making in diabetes treatment. https://www.hitachi.com/New/cnews/month/2018/03/180312h.html

(2)

Type 2 diabetes mellitus: Unlike Type 1 diabetes, in which insulin is hardly secreted from the pancreas, type 2 diabetes is a clinical condition wherein insulin secretion and action decreases. Lifestyle is considered to have a major influence on the disease.

(3)

Open Clinical Decision Support (OpenCDS) is a standard-based, open-source clinical decision support system developed by the University of Utah. http://www.opencds.org/

(4)

HL7® FHIR®(5): Health Level Seven International Fast Healthcare Interoperability Resources: Next generation health IT standard specification. https://www.hl7.org/fhir/

(5)

RESTful: A software design suitable for cooperation among multiple system in a distributed system.

(6)

Hybrid Learning: Hitachi’s technology concept that fuse conventional knowledge and AI.

(7)

HbA1c (Hemoglobin A1c) value: Laboratory test value that reflects average blood sugar level for the past three months. It serves as the main indicator of disease control for diabetes, the target value for which is decided by the clinician and patient based on the patient’s age and condition.

About University of Utah Health

University of Utah Health is the state’s only academic health care system, providing leading-edge and compassionate medicine for a referral area that encompasses 10% of the U.S. A hub for health sciences research and education in the region, U of U Health has a $356 million research enterprise and trains the majority of Utah’s health care professionals at its Schools of Medicine and Dentistry and Colleges of Nursing, Pharmacy and Health. Staffed by more than 20,000 employees, the system includes 12 community clinics and four hospitals. For nine straight years, U of U Health has ranked among the top 10 U.S. academic medical centers in the Vizient Quality and Accountability Study, including reaching No. 1 in 2010 and 2016.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges, combining its operational technology, information technology, and products/systems. The company's consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

For more information regarding this release

Please contact the Research & Development Group, Hitachi, Ltd.
https://www8.hitachi.co.jp/inquiry/hqrd/news/en/form.jsp

Contacts

USA
Julie Kiefer
University of Utah Health
+1-801-587-1293
julie.kiefer@hsc.utah.edu

Japan
Ai Marutani
Hitachi, Ltd.
+81-3-5208-9324
ai.marutani.et@hitachi.com

4 March 2019

TARRYTOWN, N.Y. (March 4, 2019) – Team Penske and Hitachi Group today announced a continuation of their partnership for the 2019 NTT IndyCar Series season.

Team Penske will enter its 53rd year of racing competition in 2019, and Hitachi is proud to carry on its dynamic relationship with Team Penske for the eighth-consecutive season.

Team Penske and Hitachi have shared success both on and off the track since becoming partners in 2012. After a productive five-year relationship with three-time Indianapolis 500 winner Helio Castroneves, Hitachi was paired with 2017 IndyCar Series Champion Josef Newgarden beginning with the 2018 season. This year, the familiar Hitachi branding will adorn Newgarden’s No. 2 Dallara/Chevrolet for eight of the 17 IndyCar Series races.

Newgarden tied for the series lead in wins (three) and poles (four) with Hitachi in 2018, elevating his career stats to include 10 wins, six poles and the series championship just two years ago. “I can’t wait for the 2019 season to start,” said Newgarden. “We learned a lot at the Circuit of the Americas test in February and we’ll apply that to the No. 2 Hitachi Chevrolet. I’m confident in the data we collected as a team and I’m sure we’ll start the year strong.” He added, “Hitachi is a great partner for the whole team. I’m excited they’re back with us this season and I’m ready to represent them on track at St. Pete and all season long.”

Hitachi will also continue as an associate sponsor for Team Penske’s other IndyCar Series entries – the Dallara/Chevrolets driven by 2016 IndyCar Champion Simon Pagenaud, and 2014 Champion and 2018 Indianapolis 500 winner Will Power.

“Hitachi has been a terrific partner with Team Penske and we appreciate how the company has grown with our program and continued to take us in new directions,” said Penske Corporation Founder and Chairman Roger Penske. “We are all excited for the start of the 2019 INDYCAR season and we are in position to have a great 2019 with Josef racing the No. 2 Hitachi Chevy, beginning with the opening race on the Streets of St. Petersburg.”

The activation strategy around the Hitachi / Team Penske partnership includes event marketing and execution at key events and industry shows across the globe, in addition to unique at-track experiences and creative social media integration with Hitachi and its partners. “The sponsorship with Team Penske continues to provide the Hitachi Group with a tremendous opportunity to leverage the success of a great IndyCar racing team, as well as to co-create with a global leader in transportation and logistics - Penske Corporation,” said Hitachi, Ltd. President & CEO Toshiaki Higashihara. “Since 2012, Hitachi has been able to leverage digital and IoT technologies to help Penske build a successful racing team and also optimize other aspects of their business. Partnering with Penske puts Hitachi in a strong position to continue to build our global brand around Hitachi’s Social Innovation Business.”

“I’ve been engaged in the partnership with Penske as a reprentative within Hitachi since 2012. The last 8 years of IndyCar sponsorship with Team Penske has formed a win-win relationship for Hitachi, both on and off the race track, and we truly value the partnership that Hitachi and Team Penske have built,” said Rob Sharpe, SVP of Sales & Marketing at Hitachi Automotive Systems Americas, Inc. “Racing is a natural fit for our Automotive Systems business, and we look forward to expanding the awareness of the Hitachi brand through motorsports in the 2019 IndyCar Series.”

The 2019 IndyCar Series season begins Sunday, March 10 with the Firestone Grand Prix of St. Petersburg on the Streets of St. Petersburg, Florida. The race will be broadcast on NBCSN beginning at 12:30 PM EST.

2019 NTT INDYCAR SERIES Hitachi Primary Sponsored Races*

DatePlaceRace Course
March 10 (Sun.)Firestone Grand Prix of St. PetersburgStreets of St. Petersburg
April 14 (Sun.)Acura Grand Prix of Long BeachStreets of Long Beach
June 1 (Sat.)Chevrolet Detroit Grand Prix Race 1The Raceway at Belle Isle Park
June 2 (Sun.)Chevrolet Detroit Grand Prix Race 2The Raceway at Belle Isle Park
July 14 (Sun.)Honda Indy TorontoStreets of Toronto
July 20 (Sat.)Iowa 300Iowa Speedway
August 18 (Sun.)ABC Supply 500Pocono Raceway
September 1 (Sun.)Grand Prix of PortlandPortland International Raceway

* Races where Hitachi’s logo was prominently displayed on Hitachi contract driver, Newgarden’s car.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges, combining its operational technology, information technology, and products/systems. The company’s consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

About Hitachi Automotive Systems, Ltd.

Hitachi Automotive Systems, Ltd. is a wholly owned subsidiary of Hitachi, Ltd., headquartered in Tokyo, Japan. The company is engaged in the development, manufacture, sales and services of automotive components, transportation related components, industrial machines and systems, and offers a wide range of automotive systems including engine powertrain systems, electric powertrain systems and integrated vehicle control systems. For more information, please visit the company's website at http://www.hitachi-automotive.co.jp/en/.

About Team Penske

Team Penske is one of the most successful teams in the history of professional sports. Cars owned and prepared by Team Penske have produced more than 500 major race wins, over 570 pole positions and 34 Championships across open-wheel, stock car and sports car racing competition. Over the course of its 53-year history, the team has also earned 17 Indianapolis 500 victories, two Daytona 500 Championships, a Formula 1 win and overall victories in the 24 Hours of Daytona and the 12 Hours of Sebring. For 2019, Team Penske will compete in the NTT IndyCar Series, the Monster Energy NASCAR Cup Series, the NASCAR XFINITY Series and the IMSA WeatherTech SportsCar Championship. The team also races in the Virgin Australia Supercars Championship, in a partnership with Dick Johnson Racing, as DJR Team Penske. For more information about Team Penske, please visit www.teampenske.com.

Contacts

Jeremy Troiano
jeremy.troiano@teampenske.com

Craig Fisher
craig.fisher@hitachi-automotive.us

1 April 2019

Hitachi provides comprehensive services including operation support and facility operation related to cutting-edge radiation therapy system

Tokyo, April 1, 2019 --- Hitachi, Ltd. (TSE: 6501, "Hitachi") announced today that the radiation therapy started on April 1, 2019 at Nagamori Memorial Center of Innovative Cancer Therapy and Research at Kyoto Prefectural University of Medicine (“Nagamori Memorial Center of Innovative Cancer Therapy and Research “) which introduced Hitachi’s radiation therapy systems.

For Nagamori Memorial Center of Innovative Cancer Therapy and Research Hitachi provides comprehensive services including operation support and facility operation related to radiation therapy systems of the proton therapy system and X-ray therapy system TomoTherapy System Radixact. Those services will enable the staff of Nagamori Memorial Center of Innovative Cancer Therapy and Research to concentrate on medicine and to provide highly advanced, cutting-edge radiation oncology treatment.

Nagamori Memorial Center of Innovative Cancer Therapy and Research is one of the most advanced cancer therapy facilities that was established by the endowment of S. N. Kosan Corporation owned by Mr. Shigenobu Nagamori, the Founder, Chairman and CEO of Nidec Corporation, with an aim to contribute to Kyoto prefecture and the local residents. The facility is operated as the radiation therapy facility of Kyoto Prefectural University of Medicine, which consolidates the most advanced therapy systems including the proton therapy system at one site.

As highly advanced medical equipment, the radiation therapy systems require regular maintenance. In addition, as the first proton therapy site in Kyoto prefecture, there has been operational needs such as public awareness activities for the citizens and clinical alignment with the neighboring medical facilities for prevalence of the therapy.

Hitachi’s particle therapy system has been introduced by the world-class renowned facilities, greatly valued its proven reliability and experiences based on the track record of the system uptime of more than 98% and the long-term, fulfilling customer support system. Also, Hitachi has been offering operational support service for customer’s radiation oncology department since 2000 and has provided engineering support for introduction and stable operation of the systems required for radiation oncology examination at the contracted facilities, operation support including asset management and planning of equipment introduction.

After the proven experiences of the particle therapy system and of those operational support services for the radiation oncology department were highly evaluated, Hitachi provides the comprehensive support for operation and maintenance of the proton therapy system, operation of X-ray therapy system and facility operation as follows:

Details of Services
1. Operation and maintenance support for the proton therapy system
In order to realize speedy system maintenance, a new maintenance framework will be established both at Nagamori Memorial Center of Innovative Cancer Therapy and Research and Hitachi, under which the daily operational support, planned system check-up or remote maintenance for the proton therapy system will also be executed.

2. Operational support for X-ray therapy system
Hitachi provide the X-ray therapy system as its assets and implement maintenance. This will contribute to reduction of burden of Nagamori Memorial Center of Innovative Cancer Therapy and Research and the stable operation after the system introduction.

3. Facility operational support
Hitachi will support planning of seminars / lectures related to proton and X-ray therapy, mainly organized by Nagamori Memorial Center of Innovative Cancer Therapy and Research and provide technical explanation about the radiation therapy systems, to citizens or healthcare related parties. This service enables smooth facility operation and establishment of local alignment of medical care.

Indication about Trademarks
TomoTherapy and Radixact are the registered trademarks of Accuray Incorporated.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges, combining its operational technology, information technology, and products/systems. The company’s consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

Press Contact

Yohei Yatsuboshi
Hitachi, Ltd.
hc.koho.zq@hitachi.com

23 April 2019

Hitachi will be entering the high-growth robotic SI(1) business in North America and accelerate the global development of its digital solution business, which connects the workplace and management, by acquiring a customer base, technology, and know-how in the Operational Technology (OT) domain

Rollout of Hitachi’s robotic SI business and 4M(2) data utilization image, through acquisitions
Rollout of Hitachi’s robotic SI business and 4M(2) data utilization image, through acquisitions

Tokyo, April 24, 2019 --- Hitachi, Ltd. (TSE:6501, “Hitachi”) today announced that on April 23, 2019 it entered into a definitive contract for the acquisition of the robotic SI business mainly operated by an American headquartered company, JR Automation Technologies, LLC (CEO: Bryan Jones, “JR Automation”), from funds managed by Crestview Partners (“Crestview”). Subject to the terms and conditions of the contract, Hitachi will acquire JR Automation, which builds production lines and logistics systems using industrial robots. As a result of this acquisition, Hitachi will enter the robotic SI business in North America, which is a region that is expected to see a high rate of growth. The acquisition is expected to be executed by the end of 2019, subject to the satisfaction of certain regulatory and other customary closing conditions.

In the Industry Sector(3), Hitachi will continue to accelerate the global rollout of the robotic SI business, together with the acquisition of KEC Corporation (KEC), a Japanese robotic system integrator, for which an acquisition contract was completed by Hitachi Industrial Equipment Systems Co., Ltd. (HIES) in March 2019(4).

In 2017, Hitachi acquired Sullair, an American manufacturer and seller of air compressors, marking a full-scale entry into the North American industrial product business(5). With the acquisition of JR Automation, Hitachi will acquire JR Automation’s customer base in the OT domain, along with advanced robotic SI technologies, know-how, and resources. Additionally, the acquisition of JR Automation will allow Hitachi to further expand its Lumada Solution business, globally. Lumada is Hitachi’s advanced digital solutions, services, and technologies business, which helps customers and management turn their workplace data into insights to drive digital innovation.

In recent years, in the manufacturing and logistics fields, there has been a growing demand for automation because of decreased working age populations, intensifying global competition, and further quality improvement requirements to prevent significant product recalls. As a result, the global robot-based automation market continues to expand, with a high average growth rate exceeding 10% per year.

Since its establishment in 1980, JR Automation has been involved in the robotic SI business, building production lines that incorporate industrial robots, predominantly in North America but increasingly around the world. It is capable of designing, building, and adjusting not only specific lines but entire production lines, and demonstrates unique strengths and expertise in robot-based assembly and welding processes. As such, JR Automation has a robust customer base across a wide range of industries, including the automotive, aerospace, e-commerce, and medical device industries.

In Hitachi’s Industry Sector, as part of its efforts to become a “Best Solution Partner” for industrial customers, Hitachi is expanding its Lumada Solution business by leveraging its combined strengths in products, OT, and IT. To further strengthen the business in the OT domain, HIES executed a contract in March 2019 for the acquisition of KEC, a Japanese robotic system integrator.

The acquisition of JR Automation will allow Hitachi to acquire additional advanced technologies, know-how, and resources in the robotic SI business that JR Automation has cultivated over many years, in addition to a customer base across a broad range of industries. Meanwhile, JR Automation will use Hitachi’s advanced R&D technology and resources, aiming to add value to its robotic SI business by utilizing data.

In the Industry Sector, Hitachi will roll out a robotic SI business by leveraging the resources of JR Automation, with its customer base in the U.S. and other regions globally, in addition to HIEC and KEC, with their customer mainly bases in Japan and other parts of Asia. As a result of these initiatives, Hitachi will expand Lumada Solutions globally. Specifically, 4M data from the workplace, obtained by the robotic SI business, will allow for Lumada Solutions to expand across multiple fields, including visualization, manufacturing optimization, logistics, and maintenance. In this way, Hitachi seeks to contribute to improving the value of our customers' businesses by seamlessly visualizing and analyzing businesses as a whole, from the workplace all the way through to management.

Comment from Masakazu Aoki, Executive Vice President, Hitachi, Ltd.
“I am extremely pleased that we have reached an agreement on the acquisition of JR Automation. Securing JR Automation’s robotic SI business in North America is an important milestone for us. By providing customers with new value that combines Hitachi’s products, OT, IT, and advanced digital technologies, we will accelerate the global rollout of our Social Innovation Business.”

Comment from Mr. Bryan Jones, CEO, JR Automation
“We are very excited to partner with Hitachi to take this next step in the company’s evolution. With our combined capabilities, Hitachi and JR Automation will be a uniquely qualified global leader in next generation smart manufacturing, and this partnership will enable us to continue to drive tangible value creation for our customers through innovative custom solutions. On behalf of everyone at JR Automation, I would like to thank the team at Crestview Partners and outgoing Chairman Mike DuBose, for their outstanding partnership and leadership during this period of dramatic global growth for JR Automation.”

The acquisition price for JR Automation is US$ 1,425 million (approx. 158.2 billion yen) on a cash-free debt-free basis. The total purchase price is subject to a possible post-closing adjustment; for example, in the event of certain fluctuations in JR Automation’s net working capital or net liabilities.

Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. is acting as exclusive financial advisor to Hitachi. Goldman Sachs & Co. LLC and BofA Merrill Lynch acted as financial advisors to JR Automation and the selling shareholders.

(1)

SI: Systems Integration

(2)

4M: huMan, Machine, Material, and Method.

(3)

“Industry Sector” is one of the five key sectors identified in Hitachi’s “2021 Mid-term Management Plan.” For further details, please refer to the Hitachi, Ltd. news release dated February 1, 2019 titled “Hitachi to Strengthen Business Structures for a Transformation into a Global Leader, as Laid Out in the 2021 Mid-term Management Plan” http://www.hitachi.com/New/cnews/month/2019/02/190201b.html

(4)

Hitachi Industrial Equipment Systems news release dated March 22, 2019 titled “Hitachi Industrial Equipment Systems Entered into Agreement to Acquire KEC, Robotic System Integrator” http://www.hitachi.com/New/cnews/month/2019/03/190322.html

(5)

Hitachi, Ltd. news release dated April 25, 2017 titled “Hitachi Enters into Agreement to Acquire Air Compressor Manufacturer, Making a Full-scale Entry into the North America Industrial / Distribution Business” http://www.hitachi.com/New/cnews/month/2017/04/170425.html

Outline of JR Automation(6)

NameJR Automation Technologies, LLC
Head OfficeHolland, MI (USA)
RepresentativeCEO: Bryan Jones
Outline of BusinessRobotic System Integration
Founded1980
Capital
(end of December 2018)
Approx. US$ 224 million (approx. 24.8 billion yen)
Main Shareholders and Shareholding RatiosFunds managed by Crestview Partners (93%) (Indirect)
Others (7%)
Revenues
(Consolidated Basis)
(2018)
Approx. US$ 603 million (approx. 67 billion yen)
Total no. of Employees:
(end of March 2019)
Approx. 2,000

(6)

Converted as US$ 1 = 111 yen.

Effects on future business performance
Shareholders will be notified immediately in the event that this transfer of shares has a significant impact on Hitachi’s consolidated business results for the year ending on March 31, 2020.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges, combining its operational technology, information technology, and products/systems. The company’s consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

Presentation Material

Contacts

Ai Marutani
Hitachi, Ltd.
+81-3-5208-9324
ai.marutani.et@hitachi.com

Kensuke Katagiri
Hitachi, Ltd.
+81-3-5208-9324
kensuke.katagiri.dc@hitachi.com

 

26 April 2019

Tokyo, April 26, 2019 - Hitachi, Ltd. (TSE:6501) today announced its consolidated financial results for fiscal 2018, ended March 31, 2019.

For more information, please click here http://www.hitachi.com/New/cnews/month/2019/04/190426.html
Note: All figures were converted at the rate of 111 yen to the U.S. dollar, as of March 31, 2019.

29 July 2019

This information was filed with and made public at the Tokyo Stock Exchange at 15:00 on July 29, 2019 JST.

News Release
Presentation Material